Yamey, Gavin

Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development

Meara, J. G., Leather, A. J. M., Hagander, L., Alkire, B. C., Alonso, N., Ameh, E. A., Bickler, S. W., Conteh, L., Dare, A. J., Davies, J., et al. (2015) · The Lancet

Global Health and SurgeryHealthcare Systems and Reforms

Cited by 3,851

Global health 2035: a world converging within a generation

Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., et al. (2013) · The Lancet

Healthcare Systems and ReformsGlobal Health Care Issues

Cited by 1,220

Scaling up global health interventions: A proposed framework for success

Yamey, G. (2011) · PLoS Medicine

Health Policy Implementation ScienceGlobal Health and Surgery

Cited by 295

The men's health gap: men must be included in the global health equity agenda

Baker, P., Dworkin, S. L., Tong, S., Banks, I., Shand, T., & Yamey, G. (2014) · Bulletin of the World Health Organization

Sex and Gender in HealthcareGender Roles and Identity Studies

Cited by 253

Global health 2050: the path to halving premature death by mid-century

Jamison, D. T., Summers, L. H., Chang, A. Y., Karlsson, O., Mao, W., Norheim, O. F., Ogbuoji, O., Schäferhoff, M., Watkins, D., Adeyi, O., et al. (2024) · The Lancet

Global Health Care IssuesGlobal Health and Epidemiology

Cited by 125

It is not too late to achieve global covid-19 vaccine equity

Yamey, G., Garcia, P., Hassan, F., Mao, W., McDade, K. K., Pai, M., Saha, S., Schellekens, P., Taylor, A., & Udayakumar, K. (2022) · BMJ

Vaccine Coverage and HesitancySARS-CoV-2 and COVID-19 Research

Cited by 114

Alma Ata at 40 years: reflections from the Lancet Commission on Investing in Health

Watkins, D. A., Yamey, G., Schäferhoff, M., Adeyi, O., Alleyne, G., Alwan, A., Berkley, S., Feachem, R., Frenk, J., Ghosh, G., et al. (2018) · The Lancet

Global Health Care IssuesHealthcare Systems and Reforms

Cited by 105

Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis

Reid, M., Agbassi, Y. J. P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D., et al. (2023) · The Lancet

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 87

Financing global common goods for health: when the world is a country

Yamey, G., Jamison, D., Hanssen, O., & Soucat, A. (2019) · Health Systems & Reform

Public health and occupational medicineHealthcare Systems and Reforms

Cited by 59

How much donor financing for health is channelled to global versus country-specific aid functions?

Schäferhoff, M., Fewer, S., Kraus, J., Richter, E., Summers, L. H., Sundewall, J., Yamey, G., & Jamison, D. T. (2015) · The Lancet

International Development and AidPublic health and occupational medicine

Cited by 54

International funding for global common goods for health: an analysis using the Creditor Reporting System and G-FINDER databases

Schäferhoff, M., Chodavadia, P., Martinez, S., McDade, K. K., Fewer, S., Silva, S., Jamison, D., & Yamey, G. (2019) · Health Systems & Reform

International Development and AidPublic health and occupational medicine

Cited by 32

Rich countries should tithe their vaccines

Yamey, G. (2021) · Nature

Vaccine Coverage and HesitancySARS-CoV-2 and COVID-19 Research

Cited by 27

Achieving global mortality reduction targets and universal health coverage: the impact of COVID-19

Mao, W., Ogbuoji, O., Watkins, D., Bharali, I., Nsiah-Boateng, E., Diab, M. M., Dwomoh, D., Jamison, D. T., Kumar, P., Kennedy McDade, K., et al. (2021) · PLOS Medicine

Healthcare Systems and ReformsGlobal Maternal and Child Health

Cited by 18

Essential packages of health services in low-income and lower-middle-income countries: what have we learnt?

Alwan, A., Yamey, G., & Soucat, A. (2023) · BMJ Global Health

Healthcare Systems and ReformsGlobal Maternal and Child Health

Cited by 13

Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries

Schäferhoff, M., Zimmerman, A., Diab, M. M., Mao, W., Chowdhary, V., Gill, D., Karanja, R., Madikizela, M., Ogbuoji, O., & Yamey, G. (2022) · The Lancet Global Health

Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life

Cited by 11